Kratom Drug Testing: What Employers Need to Know

Jared Rosenthal
Updated

Kratom use has increased significantly across the United States in recent years, creating new questions for employers, compliance officers, and safety managers. As awareness grows, many organizations are asking a practical and strategic question: Does a kratom drug test exist, and should it be part of a workplace testing program?

Because kratom is not included in most standard workplace drug panels, confusion is common. Employers may assume it would appear as an opioid on a routine test, while others may not realize it can be detected at all. Understanding how kratom works, how it is regulated, and how testing is performed is essential before making policy decisions.

This guide explains what kratom is, whether it appears on standard drug tests, how specialized kratom drug testing works, and what employers should consider when evaluating risk.

Register Now

Listen to article

expand_less

What Is Kratom?

Kratom is a plant-derived substance made from the leaves of Mitragyna speciosa, a tropical tree native to Southeast Asia. Traditionally, the leaves were used in countries such as Thailand and Malaysia for their stimulating and analgesic properties. In the United States, kratom is typically sold in powder, capsule, tablet, or liquid extract form and marketed as an herbal supplement.

Kratom's effects depend largely on dosage. At lower amounts, it can produce stimulant-like effects, including increased energy and alertness. At higher doses, it produces opioid-like effects such as pain relief, sedation, and relaxation.

The plant's primary active compounds are mitragynine and 7-hydroxymitragynine. These alkaloids interact with opioid receptors in the brain, particularly mu-opioid receptors, although they are chemically distinct from traditional opioids such as morphine or heroin. Because of this receptor activity, some individuals use kratom for pain management or to self-manage opioid withdrawal symptoms.

However, kratom is not approved by the U.S. Food and Drug Administration (FDA) for any medical use. The FDA has raised concerns regarding its safety, potential for dependency, and inconsistent product quality. Unlike prescription medications, kratom products are not subject to standardized manufacturing controls, which means potency and purity can vary widely.

Kratom's legal status exists in a regulatory gray area. At the federal level, it is not currently scheduled under the Controlled Substances Act. However, the Drug Enforcement Administration (DEA) has classified it as a "Drug and Chemical of Concern," and the FDA has issued multiple public health warnings about its safety.

State and local laws vary considerably. Some states and municipalities have banned or restricted kratom sales, while others permit its sale with few limitations. Because of this patchwork regulatory landscape, employers should review state-specific laws before implementing substance-specific workplace policies.

Does Kratom Show Up on a Standard Drug Test?

In most cases, kratom does not appear on standard workplace drug tests.

Traditional 5 panel and 10 panel drug screens are designed to detect specific substances such as marijuana (THC), cocaine, amphetamines, phencyclidine (PCP), and certain opioids like morphine and codeine. Kratom's primary compounds, mitragynine and 7-hydroxymitragynine, are chemically different from these substances and are not targeted in routine screening panels.

As a result, an employee using kratom will typically test negative on a standard drug test unless the panel has been specifically expanded to include kratom alkaloids.

What Is a Kratom Drug Test?

A kratom drug test is a specialized laboratory analysis designed to detect mitragynine and related metabolites. Unlike routine immunoassay screens used in standard workplace testing, kratom detection typically requires more advanced analytical methods such as liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS).

These tests are generally performed in forensic or specialized toxicology laboratories rather than through rapid point-of-care testing devices. Because kratom testing is not part of federally mandated drug panels, availability and methodology may vary between laboratories.

Detection Windows for Kratom

Research on kratom detection windows is still evolving, and standardized federal guidelines do not currently exist. However, available data suggest that kratom may be detectable in urine for approximately one to nine days after use, depending on factors such as frequency, dosage, and individual metabolism.

Blood testing generally reflects a shorter window of detection, while hair testing may detect repeated or long-term use if specifically included in the testing panel. However, kratom is not part of standard hair drug testing programs and must be specifically requested.

Because testing protocols are not federally standardized, detection thresholds and reporting criteria can differ between laboratories.

Why Employers Are Paying Attention to Kratom

Although kratom is often marketed as a natural supplement, it presents several workplace considerations.

First, impairment risk is a concern. At higher doses, kratom can produce sedation, dizziness, slowed reaction time, and cognitive impairment. In safety-sensitive environments such as transportation, construction, healthcare, or manufacturing, these effects may increase accident risk.

Second, repeated use may lead to tolerance and dependence in some individuals. Withdrawal symptoms have been reported and may include irritability, insomnia, muscle aches, and mood changes.

Finally, product variability creates uncertainty. Because kratom is not FDA-approved or regulated as a pharmaceutical drug, product potency and contamination risks can vary significantly, complicating risk assessment.

Should Employers Add Kratom to Their Drug Testing Program?

Whether to include kratom in a drug testing program depends on industry, risk exposure, and workforce trends.

Organizations operating in safety-sensitive sectors or high-liability environments may consider expanded toxicology panels if they have reason to believe kratom use presents a measurable safety risk. Similarly, employers conducting post-incident investigations may opt for broader toxicology testing when impairment is suspected, but standard panels are negative.

However, before expanding testing programs, employers should consult legal counsel and review applicable state laws. In some cases, focusing on impairment-based policies rather than substance-specific bans may provide a more practical and legally defensible approach.

Kratom and DOT-Regulated Testing

Kratom is not included in the Department of Transportation (DOT) mandated drug testing panels. Employers regulated by DOT must follow federally established testing requirements and may not modify those panels for regulated testing purposes.

Non-DOT programs, however, may incorporate expanded panels where legally permissible.

Why Employers Choose Health Street for Kratom Drug Testing

When kratom use is suspected, or workplace safety is a priority, many employers find that standard drug panels aren't enough, because kratom doesn't appear on routine tests. That's where Health Street's specialized kratom drug testing solutions come in.

Health Street offers reliable, laboratory-verified kratom testing that detects mitragynine, the primary compound associated with kratom use, using certified laboratory methods. This gives employers clear and defensible documentation when they need dependable results beyond standard screens.

Specialized Kratom Drug Test Options

Health Street provides several kratom testing formats to match different workplace needs:

These varied test offerings allow organizations to tailor their approach based on risk, safety sensitivity, and regulatory requirements.

Reliable Testing and Easy Access

Health Street's kratom drug test results are delivered electronically through GLASS, a secure reporting platform that simplifies access to results and supports compliance documentation. With thousands of clinics nationwide, scheduling testing is convenient for employers and employees alike.

What Sets Health Street Apart

Employers choose Health Street for kratom drug testing because of:

By offering targeted kratom testing services alongside other employment screening tools, Health Street helps employers address emerging substance trends with confidence and clarity.

Final Thoughts: Understanding Kratom Drug Testing

Kratom presents a unique challenge for employers. It is legal in many jurisdictions, not included in routine drug testing panels, and yet capable of producing psychoactive and potentially impairing effects.

A kratom drug test does exist, but it requires specialized laboratory analysis and is not part of standard workplace screening. For most employers, the key considerations are workplace safety, regulatory compliance, and consistent policy enforcement.

As emerging substances continue to evolve, proactive policy review and informed testing strategies are essential to managing risk effectively while maintaining legal and operational clarity.

Frequently Asked Questions

Does kratom show up on a drug test?

In most cases, kratom does not show up on a standard 5-panel or 10-panel drug test. Traditional workplace drug screens are designed to detect substances such as marijuana, cocaine, amphetamines, PCP, and certain opioids. Kratom's primary compounds—mitragynine and 7-hydroxymitragynine—are chemically different and are not included in routine testing panels. Detecting kratom requires a specialized laboratory test.

What kind of drug test detects kratom?

Kratom can be detected through advanced laboratory testing methods, most commonly using liquid chromatography with tandem mass spectrometry (LC-MS/MS). These highly specific analytical techniques are capable of identifying mitragynine and related metabolites in biological samples such as urine or blood. Kratom is not typically detected through rapid point-of-care tests.

How long does kratom stay in your system?

Detection time varies depending on dose, frequency of use, metabolism, and the type of test performed. Available data suggest kratom may be detectable in urine for approximately 1 to 9 days after use. Blood testing generally reflects a shorter detection window, while hair testing may identify repeated use if specifically included in the panel. Because kratom testing is not federally standardized, detection thresholds may vary by laboratory.

Can kratom cause a false positive for opioids?

Kratom does not typically cause a confirmed positive result for traditional opioid drug tests. Although kratom interacts with opioid receptors in the brain, its chemical structure differs from substances like morphine or heroin. Standard opioid immunoassays are not designed to detect kratom alkaloids. Confirmatory testing methods further reduce the risk of false positives.

Is kratom included in DOT drug testing?

No. Kratom is not part of the Department of Transportation (DOT) mandated drug testing panels. DOT-regulated employers must follow federally approved testing requirements and cannot independently add substances to regulated testing programs. However, non-DOT workplace programs may include expanded panels where legally permissible.

Can hair testing detect kratom?

Hair testing may detect kratom if the laboratory specifically includes mitragynine and related compounds in the analysis. However, kratom is not included in standard hair drug testing panels. Employers interested in hair-based kratom detection must request a customized or expanded toxicology panel.

Is there a rapid or instant kratom test?

Rapid or instant kratom tests are not commonly used in workplace settings. Most kratom detection requires laboratory-based confirmatory testing due to the need for highly specific analytical methods. Employers seeking kratom testing should work with laboratories capable of advanced toxicology analysis.

Jared Rosenthal
WRITTEN BY

Jared is the visionary behind Health Street. Raised in central Jersey, he developed an early entrepreneurial spirit, inspired by summers spent helping his family’s business on the Wildwood, NJ boardwalk. After earning both bachelor’s and master’s degrees from the University of Michigan, Jared worked in healthcare and marketing, eventually leading large-scale community health initiatives with a focus on accessibility and cultural sensitivity. His journey with Health Street began as he combined his drive for entrepreneurship with a commitment to making a difference in people’s lives.

Drug Testing
FEATURED IN

Drug Testing

Read Health Street's dramatic and informative drug testing stories.